MedPath

Gait Retraining to Reduce Joint Loading, Inflammation, and PTOA Risk

Not Applicable
Conditions
Anterior Cruciate Ligament Reconstruction
Registration Number
NCT03551678
Lead Sponsor
VA Palo Alto Health Care System
Brief Summary

The purpose of this study is to determine changes to knee joint loading, biological markers, and cartilage structure following a novel active feedback gait retraining program in anterior cruciate ligament reconstructed patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
45
Inclusion Criteria
  • age 18-40 years
  • history of primary ACLR with or without meniscal repair
  • full weight-bearing status
  • neutral to varus knee alignment
  • plans to remain in the area for at least 8 months.
Exclusion Criteria
  • Kellgren-Lawrence (KL) radiographic grade > 2
  • additional injury or surgery to the involved knee
  • BMI >30 kg/m2
  • use of walking, orthopedic, or prosthetic assistive device
  • pregnancy
  • inability to have MRI

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Knee Adduction MomentChange from baseline to immediately after 8 weeks of retraining

Knee Joint Loading (%Bw\*Ht) will be assessed at baseline and immediately after gait retraining

Secondary Outcome Measures
NameTimeMethod
Medial knee compartment qMRIChange from baseline to 6 months after retraining

Changes to quantitative MRI measures at 6 months after retraining will be correlated with changes to joint loading

Serum inflammatory markersChange from baseline to immediately after 8 weeks of retraining

Changes to serum inflammatory markers immediately after the end of training from baseline will be correlated with changes to joint loading

Knee Adduction MomentChange from baseline to 6 months after retraining

Knee Joint Loading (%Bw\*Ht)

Trial Locations

Locations (1)

VA Palo Alto

🇺🇸

Palo Alto, California, United States

VA Palo Alto
🇺🇸Palo Alto, California, United States
Constance R Chu, MD
Contact
650-721-7618
chucr@stanford.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.